GCP
FMTX

GSA Capital Partners’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

GSA Capital Partners’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16,845
Closed -$157K – 1950
2022
Q1 		$157K Buy
16,845
+1,255
+8% +$13.4K 0.02% 1226
2021
Q4 		$222K Buy
+15,590
New +$270K 0.03% 1145

Other funds holding FMTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
EPL
EDBI Pte Ltd Singapore $94.4M AUM 32.71% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

GSA Capital Partners's FMTX Position: Q2 2022 in Review

GSA Capital Partners sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q2 2022, closing a stake of 16,845 shares — an estimated $157K sold.

GSA Capital Partners first reported a position in FMTX in Q4 2021 and held it in 2 quarters. The position peaked at $222K in Q4 2021. 105 funds tracked by Wall St. Rank hold FMTX as of Q2 2022.

  • GSA Capital Partners reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • GSA Capital Partners sold 16,845 Forma Therapeutics Holdings, Inc. Common Stock shares in Q2 2022, an estimated $157K.
  • GSA Capital Partners first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • GSA Capital Partners's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $222K in Q4 2021.
  • 105 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q2 2022.

Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.